Peer-reviewedCC BY 4.0Systematic Reviews
SodiUm Glucose cotransport 2 and combined 1/2 inhibitors: a systematic Review and network meta-analysis of efficacy and safety in Heart Failure across the range of ejection fraction and with or without diabetes multimorbidity (SUGAR-HF)
Related
- Efficacy of phosphodiesterase-3 (PDE-3) inhibitors for the treatment of cerebral vasospasm in patients with aneurysmal subarachnoid haemorrhage (aSAH) admitted to the intensive care unit (ICU): a systematic review and meta-analysis protocol
- Efficacy of anlotinib plus immune checkpoint inhibitors in soft-tissue sarcoma: systematic review and meta-analysis
- Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and PD-1 inhibitors for unresectable hepatocellular carcinoma: a meta-analysis
- Efficacy of combined therapies on degenerative joint disease of the temporomandibular joint: A systematic review and meta-analysis
- Efficacy and safety of immune checkpoint inhibitors combined with TKIs for recurrent or metastatic cervical cancer with PIK3CA mutation
BibTeX
@article{tiwari2026sodium,
title = {{SodiUm Glucose cotransport 2 and combined 1/2 inhibitors: a systematic Review and network meta-analysis of efficacy and safety in Heart Failure across the range of ejection fraction and with or without diabetes multimorbidity (SUGAR-HF)}},
author = {Krishna Tiwari and Muhammad Aaqib Shamim and Vikas Kumar Tiwari and Mohit Dadhich and Aswini Saravanan and Abhishek Anil and Gopala Krishna Medarametla and Rahul Gudaghe and Pradeep Dwivedi and Surjit Singh and Sneha Ambwani and Atul Kaushik and Rahul Choudhary and Surender Deora and Shoban Babu Varthya},
journal = {Systematic Reviews},
year = {2026},
month = nov,
doi = {10.1186/s13643-026-03372-x},
url = {https://link.springer.com/article/10.1186/s13643-026-03372-x},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - SodiUm Glucose cotransport 2 and combined 1/2 inhibitors: a systematic Review and network meta-analysis of efficacy and safety in Heart Failure across the range of ejection fraction and with or without diabetes multimorbidity (SUGAR-HF)
AU - Krishna Tiwari
AU - Muhammad Aaqib Shamim
AU - Vikas Kumar Tiwari
AU - Mohit Dadhich
AU - Aswini Saravanan
AU - Abhishek Anil
AU - Gopala Krishna Medarametla
AU - Rahul Gudaghe
AU - Pradeep Dwivedi
AU - Surjit Singh
AU - Sneha Ambwani
AU - Atul Kaushik
AU - Rahul Choudhary
AU - Surender Deora
AU - Shoban Babu Varthya
PY - 2026
DA - 2026/11/07
JO - Systematic Reviews
DO - 10.1186/s13643-026-03372-x
UR - https://link.springer.com/article/10.1186/s13643-026-03372-x
SN - 2046-4053
ER -